Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Proton Pump Inhibitors Could Get Boost From COX-2 Concerns OF FDA Cmte.

Feb 22 2005

• By Lee Kalowski

Related Content

COX-2 Cardio Risk Is Class Effect, But Varies By Drug And Dose, Cmte. Says

Feb 18 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window